Authors: Laverdiere, M Rotstein, C Bow, EJ Roberts, RS Ioannou, S Carr, D Moghaddam, N

Citation: M. Laverdiere et al., Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients, J ANTIMICRO, 46(6), 2000, pp. 1001-1008

Authors: Hardy, D Amsterdam, D Mandell, LA Rotstein, C

Citation: D. Hardy et al., Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci, ANTIM AG CH, 44(3), 2000, pp. 802-805

Authors: Rotstein, C Bow, EJ Laverdiere, M Ioannou, S Carr, D Moghaddam, N

Citation: C. Rotstein et al., Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: Benefit based on purpose and intensity of cytotoxic therapy, CLIN INF D, 28(2), 1999, pp. 331-340

Authors: Yamamura, DLR Rotstein, C Nicolle, LE Ioannou, S Johnston, L Schlech, W Thompson, GW Beliveau, C Gourdeau, M Tremblay, CA Bourgault, AM Noel, G St Germain, G Garber, G Evans, G Conly, J Krajden, S Walmsley, S Wang, E Rotstein, C Gregson, D Nicolle, L Williams, K Louie, T Phillips, P

Citation: Dlr. Yamamura et al., Candidemia at selected Canadian sites: Results from the fungal disease registry, 1992-1994, CAN MED A J, 160(4), 1999, pp. 493-499

Authors: Grossman, RF Campbell, DA Landis, SJ Garber, GE Murray, G Stiver, HG Saginur, R McIvor, RA Laforge, J Rotstein, C Dubois, J Rivard, M Boulerice, F

Citation: Rf. Grossman et al., Treatment of community-acquired pneumonia in the elderly: the role of cefepime, a fourth-generation cephalosporin, J ANTIMICRO, 43(4), 1999, pp. 549-554